Margarita Perez, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5272 River Rd, Suite 300, Bethesda, MD 20816 Phone: 301-718-1716 Fax: 301-718-1766 |
Robin Levenson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9300 Wadsworth Dr, Bethesda, MD 20817 Phone: 240-740-1080 |
Kristen Ford, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6410 Rockledge Dr, Nrh Regional Rehab - Suite 600, Bethesda, MD 20817 Phone: 301-581-8054 Fax: 301-564-0284 |
Ravinder Basi, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8001 Lynbrook Dr, Bethesda, MD 20814 Phone: 240-740-5500 |
Margaret Rose Featherstone Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8001 Lynbrook Dr, Bethesda, MD 20814 Phone: 240-740-5500 |
Jessica Hutter Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4504 Fairfield Dr, Bethesda, MD 20814 Phone: 301-881-1394 |
Amanda Posegay, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4400 E West Hwy Ste 32, Bethesda, MD 20814 Phone: 833-587-1784 |
Suzanne Coyle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6410 Rockledge Dr, Nrh Regional Rehab - Suite 600, Bethesda, MD 20817 Phone: 301-581-8054 Fax: 301-564-0284 |
Alexander Whelan, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 Shields Dr, Bethesda, MD 20817 Phone: 301-493-0023 Fax: 301-493-8230 |
Suzanne Podberesky Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 Shields Dr, Bethesda, MD 20817 Phone: 301-493-0023 |
Judith Segal Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5800 Cromwell Dr, Bethesda, MD 20816 Phone: 240-740-0820 |
Ms. Jill Healey, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5100 Acacia Ave, Bethesda, MD 20814 Phone: 301-897-0815 Fax: 301-897-0819 |
Jennifer C Gershman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5404 Linden Ct, Bethesda, MD 20814 Phone: 301-758-4165 |
Mrs. Elizabeth Moschler Huet, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: National Naval Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889 Phone: 301-295-2305 |
Leticia Messam-parker, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4641 Montgomery Ave Ste 300, Bethesda, MD 20814 Phone: 301-288-1313 |
Denise Frankoff, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6410 Rockledge Dr, Nrh Regional Rehab - Suite 600, Bethesda, MD 20817 Phone: 301-581-8054 Fax: 301-564-0284 |
Mrs. Jennifer Gaum Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8625 Hempstead Ave, Bethesda, MD 20817 Phone: 240-426-8401 |
Francesca Lucia Rush, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4954 N Palmer Rd, Bldg 19, 5th Floor, Bethesda, MD 20889 Phone: 301-400-1968 |
Mary E. Carr & Associates, P.a. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7819 Marion Ln, Bethesda, MD 20814 Phone: 301-787-4505 |
Dr. Angela M Dietsch, PH.D., L/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bldg 19, Floor 5, Hearing & Speech Center, Bethesda, MD 20889 Phone: 301-295-2370 |
News Archive
In a study published in Nature, researchers from University Hospital Tübingen have been investigating the results from a Phase I trial for a new vaccine against SARS-CoV-2 variants.
Better procedures and training are needed to improve the care of prisoners in general hospitals, argue doctors in a letter to this week's British Medical Journal.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus.
Scientists will only make real breakthroughs in children's medicine if they include children in research programmes as well as adults, according to a leading paediatric expert.
› Verified 1 days ago